Free Trial

Lonza Group (LZAGY) Stock Forecast & Price Target

Lonza Group logo
$68.19 +0.38 (+0.56%)
As of 05/23/2025 03:58 PM Eastern

Lonza Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
3

Based on 3 Wall Street analysts who have issued ratings for Lonza Group in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 3 analysts, 3 have given a strong buy rating for LZAGY.

Consensus Price Target

N/A

Get the Latest News and Ratings for LZAGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Lonza Group and its competitors.

Sign Up

LZAGY Analyst Ratings Over Time

TypeCurrent Forecast
5/24/24 to 5/24/25
1 Month Ago
4/24/24 to 4/24/25
3 Months Ago
2/24/24 to 2/23/25
1 Year Ago
5/25/23 to 5/24/24
Strong Buy
3 Strong Buy rating(s)
3 Strong Buy rating(s)
3 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Strong Buy
Strong Buy
Strong Buy
Buy

LZAGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

LZAGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Lonza Group Stock vs. The Competition

TypeLonza GroupMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.81
2.54
Consensus RatingStrong BuyModerate BuyModerate Buy
Predicted UpsideN/A5,353.39% Upside16.40% Upside
News Sentiment Rating
Neutral News

See Recent LZAGY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/27/2024Redburn Atlantic
5 of 5 stars
J. Clark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
10/9/2024The Goldman Sachs Group
3 of 5 stars
J. Quigley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/23/2024Berenberg Bank
2 of 5 stars
S. Bray
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
10/9/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight
7/14/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:15 PM ET.


Should I Buy Lonza Group Stock? LZAGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, May 22, 2025. Please send any questions or comments about these Lonza Group pros and cons to contact@marketbeat.com.

Lonza Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Lonza Group AG:

  • The current stock price is around $67, reflecting a recent increase in value, which may indicate positive market sentiment towards the company.
  • Lonza Group AG has announced a dividend of $0.11, representing a 5.9% increase from the previous dividend, which can provide a steady income stream for investors.
  • The company operates in diverse segments such as Biologics and Cell & Gene, which are critical areas in the pharmaceutical and biotech industries, potentially leading to robust growth opportunities.
  • With a debt-to-equity ratio of 0.45, Lonza Group AG maintains a relatively low level of debt compared to its equity, suggesting financial stability and lower risk for investors.
  • The stock has recently crossed above its 50-day moving average, a technical indicator that may suggest a bullish trend and positive momentum in the stock price.

Lonza Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Lonza Group AG for these reasons:

  • The stock has experienced fluctuations, with a 12-month low of $52.23, indicating potential volatility that could pose risks for investors.
  • Despite recent positive developments, the overall market conditions can impact stock performance, and investors should be cautious of external economic factors.
  • The trading volume has been lower than average, which may suggest reduced investor interest or liquidity issues, potentially affecting the stock's price stability.
  • While the company has a solid financial position, any unforeseen challenges in the pharmaceutical or biotech sectors could adversely affect its performance.
  • Investors should consider the competitive landscape, as the biotech and pharmaceutical markets are highly competitive, which could impact Lonza Group AG's market share and profitability.

LZAGY Forecast - Frequently Asked Questions

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last twelve months. There are currently 3 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "strong buy" LZAGY shares.

According to analysts, Lonza Group's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Lonza Group more than other "medical" companies. The consensus rating for Lonza Group is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how LZAGY compares to other companies.


This page (OTCMKTS:LZAGY) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners